title: Interaction between IGF-1, inflammation, and neuropathy in the pathogenesis of acute charcot neuroarthropathy: lessons from alendronate therapy and future perspectives of medical therapy.
authors.affiliation: Internal Medicine Institute, Catholic University, L. go A. Gemelli 8, Rome, Italy. dario.pitocco@rm.unicatt.it
authors.forename: D
authors.initials: D
authors.lastname: Pitocco
authors.forename: M C
authors.initials: MC
authors.lastname: Collina
authors.forename: T
authors.initials: T
authors.lastname: Musella
authors.forename: V
authors.initials: V
authors.lastname: Ruotolo
authors.forename: S
authors.initials: S
authors.lastname: Caputo
authors.forename: A
authors.initials: A
authors.lastname: Manto
authors.forename: P
authors.initials: P
authors.lastname: Caradonna
authors.forename: M
authors.initials: M
authors.lastname: Galli
authors.forename: L
authors.initials: L
authors.lastname: Mancini
authors.forename: G
authors.initials: G
authors.lastname: Ghirlanda
mesh_terms: D000208:Acute Disease; D019386:Alendronate / Q000627:therapeutic use*; D001177:Arthropathy, Neurogenic / Q000188:drug therapy* / Q000378:metabolism; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001862:Bone Resorption / Q000188:drug therapy*; D003929:Diabetic Neuropathies / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D007249:Inflammation; D007334:Insulin-Like Growth Factor I / Q000378:metabolism*
chemical_list: D050071:Bone Density Conservation Agents; D007334:Insulin-Like Growth Factor I; D019386:Alendronate